IRIS Accounts Production v24.1.9.2 12880928 Board of Directors Board of Directors 1.10.22 30.9.23 30.9.23 false true false false false true false Ordinary 40.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh128809282022-09-30128809282023-09-30128809282022-10-012023-09-30128809282021-09-30128809282021-10-012022-09-30128809282022-09-3012880928ns15:EnglandWales2022-10-012023-09-3012880928ns14:PoundSterling2022-10-012023-09-3012880928ns10:Director12022-10-012023-09-3012880928ns10:Director22022-10-012023-09-3012880928ns10:PrivateLimitedCompanyLtd2022-10-012023-09-3012880928ns10:SmallEntities2022-10-012023-09-3012880928ns10:AuditExempt-NoAccountantsReport2022-10-012023-09-3012880928ns10:SmallCompaniesRegimeForDirectorsReport2022-10-012023-09-3012880928ns10:SmallCompaniesRegimeForAccounts2022-10-012023-09-3012880928ns10:FullAccounts2022-10-012023-09-301288092812022-10-012023-09-3012880928ns10:OrdinaryShareClass12022-10-012023-09-3012880928ns10:RegisteredOffice2022-10-012023-09-3012880928ns5:CurrentFinancialInstruments2023-09-3012880928ns5:CurrentFinancialInstruments2022-09-3012880928ns5:ShareCapital2023-09-3012880928ns5:ShareCapital2022-09-3012880928ns5:RetainedEarningsAccumulatedLosses2023-09-3012880928ns5:RetainedEarningsAccumulatedLosses2022-09-3012880928ns5:IntangibleAssetsOtherThanGoodwill2022-10-012023-09-3012880928ns5:PatentsTrademarksLicencesConcessionsSimilar2022-10-012023-09-3012880928ns5:PatentsTrademarksLicencesConcessionsSimilar2022-09-3012880928ns5:PatentsTrademarksLicencesConcessionsSimilar2023-09-3012880928ns5:PatentsTrademarksLicencesConcessionsSimilar2022-09-3012880928ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-09-3012880928ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-09-3012880928ns10:OrdinaryShareClass12023-09-3012880928ns5:RetainedEarningsAccumulatedLosses2022-09-3012880928ns5:RetainedEarningsAccumulatedLosses2022-10-012023-09-30
REGISTERED NUMBER: 12880928 (England and Wales)














SKIN SOLACE LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2023






SKIN SOLACE LTD (REGISTERED NUMBER: 12880928)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


SKIN SOLACE LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2023







DIRECTORS: L A King
J R Yeo





REGISTERED OFFICE: 14&15 Charlecote Mews
Staple Gardens
Winchester
Hampshire
SO23 8SR





REGISTERED NUMBER: 12880928 (England and Wales)





ACCOUNTANTS: Morris Crocker
Chartered Accountants
Station House
North Street
Havant
Hampshire
PO9 1QU

SKIN SOLACE LTD (REGISTERED NUMBER: 12880928)

STATEMENT OF FINANCIAL POSITION
30 SEPTEMBER 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 308 352

CURRENT ASSETS
Inventories 5 5,620 6,197
Debtors 6 5,153 3,232
Cash at bank and in hand 97,241 87,151
108,014 96,580
CREDITORS
Amounts falling due within one year 7 39,384 50,286
NET CURRENT ASSETS 68,630 46,294
TOTAL ASSETS LESS CURRENT
LIABILITIES

68,938

46,646

CAPITAL AND RESERVES
Called up share capital 8 400 400
Retained earnings 9 68,538 46,246
SHAREHOLDERS' FUNDS 68,938 46,646

SKIN SOLACE LTD (REGISTERED NUMBER: 12880928)

STATEMENT OF FINANCIAL POSITION - continued
30 SEPTEMBER 2023


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 June 2024 and were signed on its behalf by:




L A King - Director



J R Yeo - Director


SKIN SOLACE LTD (REGISTERED NUMBER: 12880928)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2023

1. STATUTORY INFORMATION

Skin Solace Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net invoiced sales of goods and services, excluding value added tax.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of nil years.

Stocks
Inventories are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to related parties and investments in non-puttable ordinary shares.

Trade and other debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, deposits with banks and other short-term highly liquid investments and bank overdrafts. In the balance sheet, bank overdrafts are shown within borrowings or current liabilities.

Trade and other creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.


SKIN SOLACE LTD (REGISTERED NUMBER: 12880928)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2023

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 9 (2022 - 11 ) .

4. INTANGIBLE FIXED ASSETS
Patents
and
licences
£   
COST
At 1 October 2022
and 30 September 2023 440
AMORTISATION
At 1 October 2022 88
Amortisation for year 44
At 30 September 2023 132
NET BOOK VALUE
At 30 September 2023 308
At 30 September 2022 352

5. INVENTORIES
2023 2022
£    £   
Stocks 5,620 6,197

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 5,153 2,529
Prepayments - 703
5,153 3,232

SKIN SOLACE LTD (REGISTERED NUMBER: 12880928)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2023

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 7 2,187
Corporation tax 16,447 17,615
Social security and other taxes 172 1,085
Directors' current accounts 20,958 29,399
Accrued expenses 1,800 -
39,384 50,286

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
1,000 Ordinary 40p 400 400

9. RESERVES
Retained
earnings
£   

At 1 October 2022 46,246
Profit for the year 63,792
Dividends (41,500 )
At 30 September 2023 68,538